Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2000
03/01/2000EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
03/01/2000EP0981620A1 Hgf polypeptides and their use in therapy
03/01/2000EP0981619A1 T1/st2-receptor ligand iii
03/01/2000EP0981618A1 Apo-2 RECEPTOR
03/01/2000EP0981617A1 Recombinant lactoferrin, methods of production from plants and uses
03/01/2000EP0981616A1 Ligand polypeptide for the g protein-coupled receptor from human pituitary glands
03/01/2000EP0981613A1 PARG, A GTPase ACTIVATING PROTEIN WHICH INTERACTS WITH PTPL1
03/01/2000EP0981600A1 Transformed microorganisms with improved properties
03/01/2000EP0981599A2 Method for increasing yields or recombinant proteins
03/01/2000EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
03/01/2000EP0981547A1 Tumor-associated antigen
03/01/2000EP0981544A2 Anti-bacterial methods and materials
03/01/2000EP0981541A1 Psca: prostate stem cell antigen
03/01/2000EP0981540A1 A NOVEL STRAIN OF $i(BACILLUS) FOR CONTROLLING PLANT DISEASES AND CORN ROOTWORM
03/01/2000EP0981537A1 An infectious clone for human parainfluenza virus type 3
03/01/2000EP0981277A1 Bionematicide with efficient ovicide activity against plant-parasitic nematodes
03/01/2000EP0981271A1 Compositions for the preservation of living biological materials and methods of their use
03/01/2000EP0702564B1 Novel attenuated pseudomonas aeruginosa strains
03/01/2000EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
03/01/2000CN1246156A Novel bacterial strains and use thereof in fermentation processes for 2-keto-L-gulonic acid production
03/01/2000CN1246155A Method for production of dicarboxylic acids
03/01/2000CN1246153A Mutant alpha-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus Licheniforms
03/01/2000CN1246152A Esterases, DNA encoding therefor and vectors and host cells incorporating same
03/01/2000CN1246151A Mutants of streptococcal toxin A and methods of use
03/01/2000CN1246147A Enzymatic process for preparation of cephalosporanic 7 beta-(4-carboxybutanamide) acid by means of modified enzyme D-aminoacid oxidase of trigonopsis variabilis produced in escherichia coli
03/01/2000CN1246145A Method for producing oxide with fermentation process
03/01/2000CN1246144A Clostridium butyricum having preventive and therapeutic effects on hepatopathy, and liver supporting agents, foods and feeds each containing culture medium thereof
03/01/2000CN1049919C Process for production of novel beer-like sparkling alcoholic beverage
03/01/2000CN1049823C Biological bacteriostat and its producing method
03/01/2000CN1049806C Plant stalk mycoprotein pig feeding stuff
02/2000
02/29/2000US6031156 Heterologous gene expression utilizing plant asparagine synthetase promoters
02/29/2000US6031151 Callus-specific promoters
02/29/2000US6031090 Molecular cloning of a 7TM receptor (GPR31A)
02/29/2000US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics
02/29/2000US6030835 Methods and composition for identifying group a streptococcus
02/29/2000US6030834 Cdna (complementary dna) of human i kappa b kinase involved in activating transcription factors and causing inflammation; for drug screening of antiinflammatory agents
02/29/2000US6030831 Tie ligand homologues
02/29/2000US6030826 Human parvulin-like protein
02/29/2000US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
02/29/2000US6030817 Transferring portion of the genome of xanthomonas campestris into a sphingomonas species enabling efficient xanthan gum production
02/29/2000US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors
02/29/2000US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01
02/29/2000US6030810 Nucleotide and amino acid sequence of voltage-gated transport protein; for diagnosis and therapy of nervous system disorders; antiepileptic agents
02/29/2000US6030807 Nucleic acid from the bacillus substilis l-arabinose operon for gene expression in prokaryotic hosts; inducible with exogenous l-arabinose and repressible with exogenous glucose
02/29/2000US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents
02/29/2000US6030798 Method of identifying a lipase for treatment of digestive disorders
02/29/2000US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy
02/29/2000US6030792 Quantitative immunoassay using capture and detection antibodies against specific amino acid sequences of collagen fragments resulting from collagenase cleavage of type ii collagen
02/29/2000US6030785 Incubating a mixture containing pkr protein kinase, a viral protein containing an interferon sensitivity determining region, and an agent to be tested; then measuring the protein kinase activity where activity indicates an antiviral agent
02/29/2000US6030784 Method for simultaneous identification of differentially expressed mRNAS and measurement of relative concentrations
02/29/2000US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae
02/29/2000US6030625 Bordetella pertussis and Bordetella parapertussis strains
02/29/2000US6030624 Mucosal immunogens for novel vaccines
02/29/2000US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
02/29/2000CA1340916C Method for enhancing production of secondary metabolites using clustered biosynthetic genes
02/24/2000WO2000010013A2 Composition and methods for exposing antigenic epitopes on cultered microorganism
02/24/2000WO2000009761A1 Improved microbial catalyst for desulfurization of fossil fuels
02/24/2000WO2000009747A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids
02/24/2000WO2000009733A1 Intracellular delivery vehicles
02/24/2000WO2000009732A1 Electroporation buffer with cryprotective capabilities
02/24/2000WO2000009727A2 Dna shuffling to produce herbicide selective crops
02/24/2000WO2000009718A1 Mass secretion/expression system of true mk family protein
02/24/2000WO2000009717A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence
02/24/2000WO2000009716A1 Method for purifying proteins and/or biomolecule or protein complexes
02/24/2000WO2000009709A2 Proteases and associated proteins
02/24/2000WO2000009707A1 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same
02/24/2000WO2000009705A2 Selection method
02/24/2000WO2000009697A2 Pesticidal toxins and genes from bacillus laterosporus strains
02/24/2000WO2000009695A2 Drug targets in candida albicans
02/24/2000WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
02/24/2000WO2000009692A1 Novel peptides capable of modulating inflammatory heart disease
02/24/2000WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009686A1 Gene
02/24/2000WO2000009679A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences
02/24/2000WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory
02/24/2000WO2000009661A1 Novel microorganisms and method for producing l-threonine using the same
02/24/2000WO2000009660A1 Novel microorganisms and method for producing l-threonine using the same
02/24/2000WO2000009658A2 Gene regulating circadian clock function and photoperiodism
02/24/2000WO2000009550A1 Vanadate resistance glycosylation 4 gene
02/24/2000WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
02/24/2000WO2000009541A1 nrdE
02/24/2000WO2000009538A2 Canine growth hormone secretagogue receptor
02/24/2000WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions
02/24/2000WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles
02/24/2000WO2000009154A1 Bacterial superantigen vaccines
02/24/2000WO2000009148A1 Vascular endothelial growth factor 3
02/24/2000WO2000009080A1 Incorporation of exogenous lactic bacteria into the oral microflora
02/24/2000WO2000008920A1 Polynucleotides controlling the expression of and coding for gene b in tomato
02/24/2000WO2000003581A8 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity
02/24/2000WO2000001808A3 IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS)
02/24/2000WO1999061597A9 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter
02/24/2000WO1999060011A9 Secretion of toxins by gram-negative bacteria
02/24/2000WO1999058692A3 Human apoptosis associated proteins
02/24/2000WO1999058684A3 Compounds from moraxella catarrhalis
02/24/2000WO1999055885A3 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
02/24/2000WO1999051722A3 Recombinant l-n-carbamoylase derived from arthrobacter aurescens, and a method for producing l-amino acids by using the same
02/24/2000WO1999042586A3 Exo1 and exo2, exocytotic proteins
02/24/2000DE19836382A1 Neues Tiermodell zur Entstehung und Therapie von Diabetes Mellitus New animal model for the pathogenesis and therapy of diabetes mellitus
02/24/2000CA2348388A1 Gene regulating circadian clock function and photoperiodism